Oncodesign Announces a Share Ownership Plan for All Employees on the Occasion of the Group’s 25th Anniversary
DIJON, France–(BUSINESS WIRE)–Regulatory News:
ONCODESIGN (Paris:ALONC) (ALONC – FR0011766229), a biopharmaceutical group specialized in precision medicine, is celebrating its 25th anniversary and announcing the launch of a new employee share ownership initiative. Carrying on from the capital increase subscribed for by the Executive Committee members in September, this transaction aims to foster engagement among the organization’s entire staff.
Establishment of the Oncodesign corporate mutual fund to support the PEE corporate savings plan
At its meeting on December 10, 2020, the Board of Directors, using the powers delegated by the Combined Shareholders’ Meeting of June 25, 2020 (15th resolution), decided on the main…